Help
Translations:Calcifediol/14/ja: Difference between revisions
From Azupedia
Jump to navigation
Jump to search
Visual
Wikitext
Latest revision as of 21:03, 12 April 2024
view source
Fire
(
talk
|
contribs
)
Bureaucrats
,
Interface administrators
,
Administrators
149,946
edits
Created page with "2016年、FDAは
慢性腎臓病
患者の二次性
副甲状腺機能亢進症
を治療する処方医薬品として、カルシフェジオール（Rayaldee）1日60マイクログラムの製剤を承認した。"
(No difference)
Latest revision as of 21:03, 12 April 2024
Information about message (
contribute
)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (
Calcifediol
)
In 2016, the FDA approved a formulation of calcifediol (Rayaldee) 60 microgram daily as a prescription medication to treat secondary [[hyperparathyroidism]] in patients with [[chronic kidney disease]].
2016年、FDAは
慢性腎臓病
患者の二次性
副甲状腺機能亢進症
を治療する処方医薬品として、カルシフェジオール（Rayaldee）1日60マイクログラムの製剤を承認した。
Navigation menu
Personal tools
English
Log in
Namespaces
Translation unit
Discussion
日本語
Views
Read
View source
View history
More
Search
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information
In other languages
LINK
投資用語集
The Motley Fool
Wikipedia ja
Wikipedia en
Create Item
Create Property
In other projects
In other languages
Add links